Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Endothelial Cell-Targeted Deletion of PPARγ Blocks Rosiglitazone-Induced Plasma Volume Expansion and Vascular Remodeling in Adipose Tissue.

Akiyama TE, Skelhorne-Gross GE, Lightbody ED, Rubino RE, Shi JY, McNamara LA, Sharma N, Zycband EI, Gonzalez FJ, Liu H, Woods JW, Chang CH, Berger JP, Nicol CJB.

J Pharmacol Exp Ther. 2019 Mar;368(3):514-523. doi: 10.1124/jpet.118.250985. Epub 2019 Jan 3.

PMID:
30606762
2.

An integrin antagonist (MK-0429) decreases proteinuria and renal fibrosis in the ZSF1 rat diabetic nephropathy model.

Zhou X, Zhang J, Haimbach R, Zhu W, Mayer-Ezell R, Garcia-Calvo M, Smith E, Price O, Kan Y, Zycband E, Zhu Y, Hoek M, Cox JM, Ma L, Kelley DE, Pinto S.

Pharmacol Res Perspect. 2017 Oct;5(5). doi: 10.1002/prp2.354.

3.

GPR120 suppresses adipose tissue lipolysis and synergizes with GPR40 in antidiabetic efficacy.

Satapati S, Qian Y, Wu MS, Petrov A, Dai G, Wang SP, Zhu Y, Shen X, Muise ES, Chen Y, Zycband E, Weinglass A, Di Salvo J, Debenham JS, Cox JM, Lan P, Shah V, Previs SF, Erion M, Kelley DE, Wang L, Howard AD, Shang J.

J Lipid Res. 2017 Aug;58(8):1561-1578. doi: 10.1194/jlr.M075044. Epub 2017 Jun 5.

4.

Phenotyping of adipose, liver, and skeletal muscle insulin resistance and response to pioglitazone in spontaneously obese rhesus monkeys.

Shang J, Previs SF, Conarello S, Chng K, Zhu Y, Souza SC, Staup M, Chen Y, Xie D, Zycband E, Schlessinger K, Johnson VP, Arreaza G, Liu F, Levitan D, Wang L, van Heek M, Erion M, Wang Y, Kelley DE.

Am J Physiol Endocrinol Metab. 2017 Apr 1;312(4):E235-E243. doi: 10.1152/ajpendo.00398.2016. Epub 2017 Jan 31.

5.

Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder.

Di Salvo J, Nagabukuro H, Wickham LA, Abbadie C, DeMartino JA, Fitzmaurice A, Gichuru L, Kulick A, Donnelly MJ, Jochnowitz N, Hurley AL, Pereira A, Sanfiz A, Veronin G, Villa K, Woods J, Zamlynny B, Zycband E, Salituro GM, Frenkl T, Weber AE, Edmondson SD, Struthers M.

J Pharmacol Exp Ther. 2017 Feb;360(2):346-355. doi: 10.1124/jpet.116.237313. Epub 2016 Dec 13.

PMID:
27965369
6.

Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis.

Strack AM, Carballo-Jane E, Wang SP, Xue J, Ping X, McNamara LA, Thankappan A, Price O, Wolff M, Wu TJ, Kawka D, Mariano M, Burton C, Chang CH, Chen J, Menke J, Luell S, Zycband EI, Tong X, Raubertas R, Sparrow CP, Hubbard B, Woods J, O'Neill G, Waters MG, Sitlani A.

J Lipid Res. 2013 Jan;54(1):177-88. doi: 10.1194/jlr.M031344. Epub 2012 Oct 28.

7.

Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty rat.

Futamura M, Yao J, Li X, Bergeron R, Tran JL, Zycband E, Woods J, Zhu Y, Shao Q, Maruki-Uchida H, Goto-Shimazaki H, Langdon RB, Erion MD, Eiki J, Zhou YP.

Diabetologia. 2012 Apr;55(4):1071-80. doi: 10.1007/s00125-011-2439-3. Epub 2012 Jan 11.

PMID:
22234649
8.

A gene expression signature that classifies human atherosclerotic plaque by relative inflammation status.

Puig O, Yuan J, Stepaniants S, Zieba R, Zycband E, Morris M, Coulter S, Yu X, Menke J, Woods J, Chen F, Ramey DR, He X, O'Neill EA, Hailman E, Johns DG, Hubbard BK, Yee Lum P, Wright SD, Desouza MM, Plump A, Reiser V.

Circ Cardiovasc Genet. 2011 Dec;4(6):595-604. doi: 10.1161/CIRCGENETICS.111.960773. Epub 2011 Oct 18.

PMID:
22010137
9.

Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice.

Mu J, Jiang G, Brady E, Dallas-Yang Q, Liu F, Woods J, Zycband E, Wright M, Li Z, Lu K, Zhu L, Shen X, Sinharoy R, Candelore ML, Qureshi SA, Shen DM, Zhang F, Parmee ER, Zhang BB.

Diabetologia. 2011 Sep;54(9):2381-91. doi: 10.1007/s00125-011-2217-2. Epub 2011 Jun 22.

PMID:
21695571
10.

Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability.

Chen Z, Ichetovkin M, Kurtz M, Zycband E, Kawka D, Woods J, He X, Plump AS, Hailman E.

Lipids Health Dis. 2010 Jun 11;9:61. doi: 10.1186/1476-511X-9-61.

11.

Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes.

Mu J, Petrov A, Eiermann GJ, Woods J, Zhou YP, Li Z, Zycband E, Feng Y, Zhu L, Roy RS, Howard AD, Li C, Thornberry NA, Zhang BB.

Eur J Pharmacol. 2009 Nov 25;623(1-3):148-54. doi: 10.1016/j.ejphar.2009.09.027. Epub 2009 Sep 16.

PMID:
19765579
12.

Potential role for epidermal Langerhans cells in nicotinic acid-induced vasodilatation in the mouse.

Carballo-Jane E, Ciecko T, Luell S, Woods JW, Zycband EI, Waters MG, Forrest MJ.

Inflamm Res. 2007 Jun;56(6):254-61.

PMID:
17607550
13.

Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia.

Conarello SL, Jiang G, Mu J, Li Z, Woods J, Zycband E, Ronan J, Liu F, Roy RS, Zhu L, Charron MJ, Zhang BB.

Diabetologia. 2007 Jan;50(1):142-50. Epub 2006 Nov 28.

PMID:
17131145
14.

Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic beta-cell mass and function in a rodent model of type 2 diabetes.

Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, Moller DE, Thornberry NA, Zhang BB.

Diabetes. 2006 Jun;55(6):1695-704.

15.

Peroxisome proliferator-activated receptor (PPAR)-alpha agonism prevents the onset of type 2 diabetes in Zucker diabetic fatty rats: A comparison with PPAR gamma agonism.

Bergeron R, Yao J, Woods JW, Zycband EI, Liu C, Li Z, Adams A, Berger JP, Zhang BB, Moller DE, Doebber TW.

Endocrinology. 2006 Sep;147(9):4252-62. Epub 2006 May 25.

PMID:
16728496
16.

Increased melanin concentrating hormone receptor type I in the human hypothalamic infundibular nucleus in cachexia.

Unmehopa UA, van Heerikhuize JJ, Spijkstra W, Woods JW, Howard AD, Zycband E, Feighner SD, Hreniuk DL, Palyha OC, Guan XM, Macneil DJ, Van der Ploeg LH, Swaab DF.

J Clin Endocrinol Metab. 2005 Apr;90(4):2412-9. Epub 2005 Jan 25.

PMID:
15671106
17.

Localization of PPARdelta in murine central nervous system: expression in oligodendrocytes and neurons.

Woods JW, Tanen M, Figueroa DJ, Biswas C, Zycband E, Moller DE, Austin CP, Berger JP.

Brain Res. 2003 Jun 13;975(1-2):10-21.

PMID:
12763589
18.

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance.

Conarello SL, Li Z, Ronan J, Roy RS, Zhu L, Jiang G, Liu F, Woods J, Zycband E, Moller DE, Thornberry NA, Zhang BB.

Proc Natl Acad Sci U S A. 2003 May 27;100(11):6825-30. Epub 2003 May 14.

19.

Collagen fibrillogenesis in situ: fibril segments become long fibrils as the developing tendon matures.

Birk DE, Zycband EI, Woodruff S, Winkelmann DA, Trelstad RL.

Dev Dyn. 1997 Mar;208(3):291-8.

20.

Characterization of collagen fibril segments from chicken embryo cornea, dermis and tendon.

Birk DE, Hahn RA, Linsenmayer CY, Zycband EI.

Matrix Biol. 1996 Jul;15(2):111-8.

PMID:
8837012
22.

Assembly of the tendon extracellular matrix during development.

Birk DE, Zycband E.

J Anat. 1994 Jun;184 ( Pt 3):457-63. Review.

23.

Assembly of the collagenous extracellular matrix during tendon development in the chicken limb.

Birk DE, Zycband E.

Prog Clin Biol Res. 1993;383B:523-32. No abstract available.

PMID:
8115369
24.

Electron microscopy of single detached glomerulus in needle biopsy tissue.

Shimamura T, Zycband E, Covit A, Eisinger RP.

Acta Pathol Jpn. 1992 Nov;42(11):852-3. No abstract available.

PMID:
1471534
25.
26.

Collagen fibrillogenesis in situ. Discontinuous segmental assembly in extracellular compartments.

Birk DE, Zycband EI, Winkelmann DA, Trelstad RL.

Ann N Y Acad Sci. 1990;580:176-94. No abstract available.

PMID:
2337297
27.

Collagen fibril bundles: a branching assembly unit in tendon morphogenesis.

Birk DE, Southern JF, Zycband EI, Fallon JT, Trelstad RL.

Development. 1989 Nov;107(3):437-43.

28.

Collagen fibrillogenesis in situ: fibril segments are intermediates in matrix assembly.

Birk DE, Zycband EI, Winkelmann DA, Trelstad RL.

Proc Natl Acad Sci U S A. 1989 Jun;86(12):4549-53.

Supplemental Content

Loading ...
Support Center